Using population-based screening outcomes of approximately 3 million infants, a team of scientists across 14 states, including four researchers at UMass Medical School, have shown that newborn screening for severe combined immunodeficiency (SCID) can be successfully implemented across public health newborn screening programs. Data from 11 newborn screening programs published in the Aug. 20 issue of the Journal of the American Medical Association (JAMA) showed the rate of SCID in newborns is higher than previously thought and believed to be 1 in 58,000.
The Blue Cross Blue Shield of Massachusetts (BCBSMA) Foundation’s Connecting Consumers with Care grant program can serve as a model for other organizations, states or policymakers interested in supporting and training outreach workers enrolling consumers into health plans, according to a new report developed by UMass Medical School.
A report produced by UMass Medical School that lays the groundwork for how Vermont will finance its revolutionary single-payer health care systems was featured in a The Pew Charitable Trusts Stateline article.
How one drop of her blood changed Madeleine M. Stout’s life was chronicled in an overview of the Massachusetts Newborn Screening Program published in the Mount Holyoke College Alumnae Quarterly. UMass Medical School has operated the program on behalf of the state Department of Public Health since 1997.
Warren Ferguson, MD, a correctional health expert at UMass Medical School, talked to The New York Times about the high cost of treating Hepatitis C-infected inmates with the expensive new drug Sovaldi.
Testing newborns for Severe Combined Immunodeficiency (SCID) is inexpensive and lifesaving, Anne Marie Comeau, PhD, deputy director of UMass Medical School’s New England Newborn Screening Program and an expert in the field, explained to The Boston Globe.
More academic health centers should partner with correctional facilities to improve clinical care and advance education and research, according to an Academic Medicine commentary co-authored by Warren Ferguson, MD, professor and vice chair of family medicine & community health and a correctional health expert at UMass Medical School.
UMass Medical School’s Work Without Limits program, within the Commonwealth Medicine division, is helping people with disabilities find jobs, according to a story in the July 1 Boston Globe.
As Massachusetts confronts an opioid abuse and misuse crisis, Maria Garcia, MD, MPH, associate professor of medicine, says clinicians need to assist patients addicted to the powerful drugs by supporting both their physical and mental health needs.
The National AHEC Organization (NAO) has named UMass Medical School’s Warren Ferguson, MD, the recipient of its 2014 Andy Nichols Award for Social Justice. Dr. Ferguson, vice chair and professor of family medicine & community health and medical director of the Mass Area Health Education Center (MassAHEC) Network, will accept the award on July 10 at the annual NAO Conference in Charlotte, North Carolina.
New recommendations on how pharmacists should manage opioid prescriptions are expected to be released by Gov. Deval Patrick’s Opiate Emergency Task Force this month and Paul L. Jeffrey, PharmD, pharmacy director at Commonwealth Medicine and an active participant on the task force, said pharmacists will embrace the suggestions.
Harvard Pilgrim Health Care has named Joyce A. Murphy, MPA, executive vice chancellor of UMass Medical School’s Commonwealth Medicine division, vice chair of its Board of Directors. Murphy will serve alongside Chairperson Mary Ann Tocio, president and chief operating officer of Bright Horizons Family Solutions.
A survey reveals that 45 percent of the state’s residents have been told they have a chronic condition, according to the Hartford Business Journal.
The Federal Bureau of Prisons has awarded UMass Medical School a multimillion dollar contract to manage comprehensive medical services for nearly 1,000 inmates at the Federal Correctional Institution (FCI) located in Ray Brook, New York.